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Compared to two-dimensional (2D) cell culture, cellular aggregates or spheroids
(3D) offer a more appropriate alternative in vitro system where individual cell-cell
communication and micro-environment more closely represent the in vivo organ; yet
we understand little of the physiological conditions at this scale. The relationship
between spheroid size and oxygen microenvironment, an important factor influencing
the metabolic capacity of cells, was first established using the fish intestine
derived RTgutGC cell line. Subsequently, pharmaceutical metabolism (Propranolol), as
determined by high performance liquid chromatography, in this intestinal model was
examined as a function of spheroid size. Co-efficient of variation between spheroid size
was below 12% using the gyratory platform method, with the least variation observed
in the highest cell seeding density. The viable, high oxygen micro-environment of the
outer rim of the spheroid, as determined by electron paramagnetic resonance (EPR)
oximetry, decreased over time, and the hypoxic zone increased as a function of spheroid
size. Despite a trend of higher metabolism in smaller spheroids, the formation of micro-
environments (quiescent, hypoxic or anoxic) did not significantly affect metabolism or
function of an environmentally relevant pharmaceutical in this spheroid model.
Keywords: spheroids, EPR-oximetry, micro-environment, metabolism, intestine, β-blocker, propranolol
INTRODUCTION
The spheroid (three-dimensional or 3D) culture system is a model used increasingly in study
function, metabolism and toxicological assessment of drugs and contaminants across a broad
range of biological systems (Sutherland et al., 1981; Ma et al., 2003; Xu et al., 2003; Curcio et al.,
2007; Hirschhaeuser et al., 2010; Baron et al., 2012; Mehta et al., 2012; Cueto et al., 2013; Uchea
et al., 2015). While microenvironment gradient formation has been well characterized in terms
of oxygen diffusion in tumor based spheroid models (Mueller-Klieser, 1984; Sutherland et al.,
1986; Vaupel et al., 1989; Hashem et al., 2015), questions still remain in terms of nutrient and
xenobiotic diffusion/or metabolism in non-tumorous spheroid models. Beginning with the route
of administration and uptake to the final site of action, a drug/toxicant encounters numerous
barriers and transporters before reaching its target. Transporters play a key role in the uptake of
Frontiers in Pharmacology | www.frontiersin.org 1 August 2018 | Volume 9 | Article 947
fphar-09-00947 August 22, 2018 Time: 12:33 # 2
Langan et al. Spheroid Size and Metabolism of Propranolol
toxicants and drugs by cells, with the largest family of
transporters known as the ATP binding cassette (ABC) which
include P-glycoprotein (Pgp). These proteins function as active
transporters for multiple substrates across the cellular membrane
and are highly conserved across animal taxa (Jeong et al.,
2017). However, in cells cultivated as a 3D construct, oxygen
is transported by diffusion and simultaneously consumed by
cells (Curcio et al., 2007). In this context, a clear trend
emerges where larger spheroids demonstrated markedly distinct
diffusional gradients which do not provide sufficient nutrients
into the core of the aggregate. As a consequence of limited
nutrients, basic cellular activity such as waste removal is reduced
resulting in eventual cell death. Any adjustment to this diffusion
has clear impacts on energy and xenobiotic metabolism and
subsequently can impact overall physiology and function of the
spheroid. Typically, studies which address energy metabolism
limitations in these models have used mathematical modeling
of growth (Venkatasubramanian et al., 2006; Curcio et al.,
2007) or cytotoxic changes in terms of quantitative changes in
glucose, LDH or protein (Ma et al., 2003; Xu et al., 2003) as a
means of minimizing the degree of variation between predictions
and reality. Regardless of the obvious connection, few studies
address the differences in xenobiotic metabolism as impacted by
spheroid size. Cytotoxic response to numerous pharmaceutical
compounds using spheroids derived from both a primary source
and a cell line was compared (Xu et al., 2003), but no attempt
was made to correlate metabolic rate with respect to spheroid cell
seeding density, size and growth.
Significant differences in responsiveness of different 3D
models following exposure to chemicals are difficult to interpret
since there is no agreed or standardized spheroid size, or
cell seeding protocol. Substantial advances in our knowledge
about these 3D models have highlighted the potential impact
of spheroid size in terms of their metabolic capability
and responsiveness. For example, recent studies identified a
maximum spheroid size where cells are exposed to sufficient
oxygen in order to prevent or minimize hypoxia in their
internal structure but did not quantify the metabolic differences
between size categories (Curcio et al., 2007; Langan et al.,
2016). It is unsurprising that reviews have focused on the
incorporation of spheroid size in terms of responsiveness to
treatment (Hirschhaeuser et al., 2010) and on opportunities
and challenges associated with the use of this model to test
drug delivery and efficacy (Mehta et al., 2012). However,
development of high-throughput preparatory methodologies
rarely addresses the impact of spheroid size and generally,
the focus is drug penetration within a spheroid in relation
to the molecular structure of the drug. Given that metabolic
capacity of spheroids could depend on the size of spheroids,
one might argue that the impact of size is important. If
different size categories of spheroids are known to have
variable zones of proliferating cells, necrosis or oxygen transport
limitations, how can a single response be standardized or
compared in vivo or in vitro in any animal or human
system? Obviously, this has significant implications while
extrapolating the information for fundamental biological or
clinical understandings.
Previously we have addressed one of the fundamental
unknowns for the widespread use of spheroid models by
elucidating oxygen micro-environment in spheroids in fish cell
line (i.e., RTG-2) derived spheroids of various sizes (Langan
et al., 2016). With precise cultivation of the spheroid size in
terms of cell seeding density, zones of quiescence can be kept
to a minimum and consequently unmodified metabolism can
occur within the model. Yet, questions regarding fundamental
characterization of how cell seeding density/spheroid size
affects the oxygen micro-environment and the xenobiotic
metabolism of the model system are still not available in the
literature. Despite an acknowledged need, there is a lack of
established cell lines derived from the gastrointestinal tract
of fish to help understand dietary exposure to chemicals
in the aquatic environment (Langan et al., 2017). The use
of the intestinal RTgutGC cell line to model metabolism
in the form of a cellular aggregate therefore provides the
opportunity to elucidate the metabolism of environmentally
relevant contaminants in the gut environment in a more complex
culture system. As described in later sections, this cell line
cultured as spheroids demonstrates comparative morphology
to the native intestine in the form of numerous polarized
micro-villi formations on the edge of the spheroid structures
which facilitates metabolism in this system and has been
previously observed in the cell line when cultured on Transwell R©
inserts (Langan et al., 2017). Staining for the presence of
mucosubstances revealed strong staining for both acidic and
neutral mucosubstances indicative of goblet cells which are
comparable to expression of the intestine in vivo. Furthermore,
available information also suggests an increasing use of intestinal
spheroid cultures (McCracken et al., 2011; Mustata et al., 2013;
Schlaermann et al., 2014), with increasing demand for teleost
derived spheroids as the requirement for animal alternatives
for fish ecotoxicological studies increases (Lillicrap et al.,
2016).
Previous studies from our laboratories have demonstrated
that the β-blocker propranolol, an environmentally relevant
pharmaceutical, is actively metabolized both by hepatocytes and
in spheroids derived from rainbow trout liver cells (Bartram et al.,
2012; Baron et al., 2017). Despite the importance, as mentioned
above, in vivo dietary uptake studies for chemicals in general
and pharmaceuticals such as propranolol are not well reported
in fish or aquatic models. Uptake of propranolol in the intestine
has been reported to be less than half that of the liver in rabbit
(Du Souich et al., 1995) and in murine systems (Okabe et al.,
2004; Masaki et al., 2006). Using the intestinal RTgutGC cell line
cultured as spheroids and propranolol as our environmentally
relevant test compound, we compared and contrasted different
size classes of spheroids to test the hypothesis that the size of
spheroids impact xenobiotic metabolism. To test this hypothesis,
we used electron paramagnetic resonance (EPR) oximetry to
determine oxygen gradients within this system as a function
of spheroid size. We further characterized the functionality
of the cell line using histochemical staining. To complement
the determination of oxygen levels in different spheroid sizes,
we used high performance liquid chromatography (HPLC) to
determine the active metabolism of propranolol.
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MATERIALS AND METHODS
Reagent and Stock Preparation
All reagents were from Sigma-Aldrich (United Kingdom) unless
otherwise indicated. Propranolol hydrochloride (99% pure, CAS
318-98-9, C16H22O2NCl) was supplied by industrial partner
(AstraZeneca). Preparation of the oximetry probe LiPc (Lithium
phthalocyanine) was carried out as previously described in detail
(Langan et al., 2016).
Cell Culture
The rainbow trout gastrointestinal cell line RTgutGC was a kind
gift from Dr. Lucy Lee (University of Fraser Valley, Canada)
(Kawano et al., 2011). The cell line was routinely cultured in
our laboratory using 75 cm2 culture flasks at room temperature
(21◦C) in L-15 culture medium supplemented with 10% FBS
(Langan et al., 2017). Cells were seeded at a density of 5 × 104
cells/mL, and became confluent 7–8 days later. Spheroids were
formed as previously outlined for another fish cell line (Langan
et al., 2016). Subsequent experiments were carried out on
spheroids of three initial seeding densities (i.e., 12.5, 50 and
100× 104 cells/mL), with a volume of 200 µL per spheroid well.
Morphological Characterization of the
RTgutGC Spheroids
The growth of individual spheroids was calculated according to
the methodology established previously in our laboratory (Baron
et al., 2012). Morphological characterization of the RTgutGC
spheroid was observed under light microscopy over 14 days,
with surface structure observed under Transmission Electron
Microscopy (TEM) and histological staining of mucosubstances
following previously established protocols (Langan et al., 2017).
Electron Paramagnetic Resonance (EPR)
Oximetry
Oxygen gradients across the spheroids were quantified as
previously described by us (Langan et al., 2016). Briefly, spectra
were recorded on a Bruker EMX micro EPR spectrometer
fitted with variable temperature accessory, operating at 9.4 GHz.
Spheroids (2 per spectra recording) were drawn into the PTFE
gas permeable tubing with ∼5 µL of medium per spheroid. The
tube was folded once, and the spheroids allowed to sediment at
the fold. Samples were maintained in the cavity at 292◦K, which
is equivalent to the incubation temperature (19◦C). Oxygen
saturation was quantified by measuring the peak to peak line
width of the spectrum relative to a sample which contained only
the probe and medium but not spheroids/cells. As per previous
experiments (Langan et al., 2016), the zone of hypoxic and anoxic
cells was quantified based on mathematical calculations (Grimes
et al., 2014) following the identification of viable rim from EPR
recordings.
Preparation of Spheroids for Exposure
Spheroids (7 days old) were pooled (for each separate
experiment) from 96-well micro plates into a clean 96-well
pHEMA-coated microplate at a seeding density of 12 spheroids
per well of the 5 × 104 cells/mL seeding and 6 spheroids per
well of the 10 × 104 cells/mL cell seeding density (in 75 µL
L-15 medium; pH 7.4). These spheroid sizes were chosen as
they adequately represent the range of spheroid radii typically
reported in the non-tumor spheroid literature. For exposure, the
spheroids were exposed to 75 µL of a solution of 200 µg/L of
propranolol (final concentration 100 µg/L in well) reconstituted
in L-15 medium and incubated at 15
◦
C for 24 h. Control samples
were quenched immediately after the addition of the exposure
solution to samples using acetonitrile.
Metabolism of Propranolol in the
Spheroids
Analyses were performed using Surveyor MS Pump Plus HPLC
pump with HTC PAL autosampler coupled to TSQ Vantage
triple quadrupole mass spectrometer equipped with heated
electrospray (HESI II) source (all ThermoFisher Scientific, Hemel
Hempstead, United Kingdom). Chromatographic separation was
achieved using reversed-phase, 3 µm particle size, C18 Hypersil
GOLD column 50 mm × 2.1 mm i.d. (Thermo Scientific,
San Jose, CA, United States). Analytes were separated using a
linear gradient of aqueous phase and Methanol both containing
0.1% of Formic Acid. Methanol content increased from 20% to
100% in 1.5 min and maintained for another 1.5 min before
returning to the initial condition. The flow rate was 500 µL/min.
Temperature of autosampler was set at 8◦C while column was
kept at a room temperature. HESI probe was operating in positive
mode while an ion-spray voltage of +3.75 kV was applied. The
heated capillary temperature was set at 270◦C and the vaporizer
temperature was 350◦C. Nitrogen was employed as sheath and
auxiliary gas at a pressure of 60 and 2 arbitrary units, respectively.
The argon CID gas was used at a pressure of 1.5 mTorr.
Quantification of propranolol was performed by monitoring
characteristic multiple reaction monitoring (MRM) transitions
260.2→116.2 m/z (collision energy 17 eV). Internal standard
method of quantification, using matrix matched standards was
used in all samples analysis.
Additionally, CYP3A quantification in the intestinal spheroid
model using the model inducer Testosterone was also examined
(Kamiguchi et al., 2010). CYP3A activity was quantified
by measuring the extent of 6β-hydroxytestosterone (H2898,
CAS: 62-99-7; Sigma) formation from testosterone using
ultraperformance liquid chromatography systems (UltiMate
3000, ThermoScientific). Stock solutions were made up in HPLC
grade methanol (Sigma, United Kingdom). Briefly, the cultured
RTgutGC cells were seeded at varying densities and washing
thrice with Hanks balanced salt solution and then incubated
with 100 µM testosterone (T1500, CAS: 58-22-0; Sigma) for 2 h.
At the end of incubation, 250 µL of the media was transferred
into a glass vial with 250 µL of methanol and the 20 µL of
the mixture injected onto the column. Samples, testosterone and
6β-hydroxytestosterone were chromatographed using Aquasil
C18 column (150 mm × 4.6 mm, 3 µm; ThermoFisher) with a
C18 security guard (Phenomenex, United Kingdom). The mobile
phase consisted of diluted methanol in water with a gradient
profile starting at 50% from 0 to 15 min, increasing to 60% until
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20 min, increasing again to 85% until 22 min before decreasing
back to 50%, all at a flow rate of 1 mL/min). The detection
limits for testosterone and 6β-hydroxytestosterone metabolites
was 0.1175 µM.
Statistical Analysis
Statistical analyses were preformed using R, Version 3.1.3
(R Core Development Team, 2015). Data is given as mean
values ± SEM, with n denoting the number of replicates per
experiment unless otherwise indicated. These replicates are
representative of non-parallel passages of the cell line, with each
recording representative of 3-4 technical replicates. Data were
first tested for normality and homogeneity of variance using the
Anderson-Darling Normality test and Levene’s test respectively.
Analysis of variance (ANOVA) was performed for multiple factor
comparisons when assumptions were met. Due to non-normality
and variable variance in micro-environment recordings, data
was analyzed using a Friedman non-parametric test. A value
of p < 0.05 was considered significant, with data presented as
p< 0.001 demonstrating highly significant results.
RESULTS
Morphological Characterization
Prior to the identification of micro-environment formation in
the RTgutGC spheroid, it was critical that spheroid growth
(across all cell seeding densities) was first established in order
to identify the point at which spheroids were formed visually
(Figure 1a) and to what size spheroids varied dependent on
initial seeding (Figure 1b). This time point (day 7) was then
used as the basis for assessment of micro-environment formation
and later for the assessment of metabolism. During formation,
the RTgutGC spheroid became significantly more compact,
FIGURE 1 | Growth of the RTgutGC cell line as spheroids. Spheroid growth progresses as normal with an obvious incorporation of individual spheroids from day 1
to day 6 (scale bar = 100 µm) where only one spheroid is visible (A), with the impact of modifying initial seeding density during spheroid formation presented (B).
A clear trend towards larger spheroids with higher initial cell seeding is clearly visible. Analysis of spheroid size via ANOVA reveals significant difference between all
size categories (p < 0.001).
Frontiers in Pharmacology | www.frontiersin.org 4 August 2018 | Volume 9 | Article 947
fphar-09-00947 August 22, 2018 Time: 12:33 # 5
Langan et al. Spheroid Size and Metabolism of Propranolol
with a reduction in size of 30 – 40% observed irrespective
of original seeding density. Transmission electron microscopy
revealed microvilli (Figure 2A). Mucosubstances in the intestine
are known to play an important role in the protection and uptake
of xenobiotics from the ingested chyme, and their presence in
the RTgutGC spheroid model was confirmed using histological
staining (Figure 2B). Indeed, the intensity of staining is directly
comparable to ex vivo adherent cultures of trout intestine
(personal observation) and to cultures of the cell line grown on
Transwell R© inserts (Langan et al., 2017).
Oxygen Micro-Environment Formation
Three experiments from non-parallel passages were recorded
on day 7 and day 14 to elucidate variation in oxygen
micro-environment formation as a function of seeding density.
Diameters of the spheroids ranged from 143 to 444 µm
(Table 1). Coefficient of variation between spheroids was
recorded to denote comparability between experiments (and
different passages) with an obvious trend toward minimization
FIGURE 2 | Characterization of the RTgutGC cell line. (A) Transmission
electron microscopy image of RTgutGC spheroids on day 7 of growth at the
lowest seeding density (i.e., 12,500 cells/mL or 2,500 cells/spheroid). Apical
protrusions of micro-villus structures are labeled and denoted by arrows. In
addition, other common cellular features are visible including rough
endoplasmic reticulum (rER), mitochondria (MT) and lysosomes (LYS).
(B) Histological sections of RTgutGC spheroids generated through gyratory
culture. Positive staining for both acidic and neutral mucosubstances via PAS
and Schiff stain of a section of spheroid (50,000 cells/mL) on day 7. Presence
of both acidic, neutral and mixtures of mucins are comparable to native
rainbow trout intestine (Khojasteh et al., 2009). Scale bar = 100 µm.
of variability in the larger size class (Table 1). Application of
Friedman’s test revealed no significant changes in distribution
of micro-environment formation over time or seeding density
(χ2 = 3, df = 2, p = 0.22) (Figure 3).
Oxygen saturation was calculated as a percentage of narrowing
line width in paramagnetic oximetry (Langan et al., 2016). While
all oxygen profiles (in all seeding densities) were characterized
by a general decrease in oxygen levels over seeding densities and
with time (Figure 3), the lack of significant differences between
models was not unexpected. Of particular interest is the apparent
increase in oxygen concentrations in spheroids with over 10,000
cells seeded which recorded an apparent increase in oxygen with
time. Partitioning of the micro-environment within the spheroid
model is displayed in Table 1. Quiescent zones (where cells are
inactive) were determined for each size class investigated (based
on differences in viable rim and oxygen diffusion distance), where
a consistent trends of zones of 19–20% of total spheroid size were
identified for all size classes.
Metabolism of Propranolol in the
Spheroids
All spheroid samples which underwent propranolol exposure
were within the analytical limit of quantification, with exposure
occurring on day 7 in order to investigate the relationship
between metabolism and micro-environment formation. The
depletion of propranolol was measured in four non-parallel
individual passages (biological variability) of the RTgutGC cell
line cultured as spheroids over 24 h, with each treatment
in quadruplicate. A Shapiro–Wilk test revealed normal data
(W = 0.9343, p = 0.29), while a Levene test revealed normal
homogeneity of variance (df = 3, f = 0.064, p = 0.98), and so
an ANOVA was applied to the data. This revealed significant
differences between time (p < 0.001), but not between seeding
densities (p = 0.81). Despite the non-significant differences
between the two seeding densities, the degree of substrate
depletion was different (Figure 4) between the lower seeding
category of 50× 104 cells/mL (n = 4, CV = 9.23%, 25% difference
between 0 and 24 h) and the higher seeding category of 100× 104
cells/mL (n = 4, CV = 2.38%, 15.25% difference between 0
and 24 h).
To investigate if the metabolism of propranolol occurred
via the CYP3A pathway, standard curves were generated
for testosterone and 6β-hydroxytestosterone as controls for
measurement of CYP3A activity in the RTgutGC cell line (2D
and 3D). No response was observed in cells seeded at any of
the concentrations used, although numerous methodologies were
tried including increasing seeding densities, incubation time,
or indeed analytical chemistry by increasing injection volume
from 20 to 100 µL, which caused no significant improvement in
resulting peak (data not shown). In order to ascertain whether
testosterone as a CYP3A inducer is cell line specific through
a minimization of enzyme activity in cell line versus native
tissue (via de-differentiation), primary cultures of rainbow trout
intestine were used as controls, with cells exposed directly
rather than allowed to attach to substrate (a suspension culture).
Primary culture observations indicate that trout intestine does
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2,500 7 3 14 68 ± 1.5 12 100 ± 5 68 13
14 14 68 ± 0.2 68 13
10,000 7 3 13 51 ± 2.7 11 144 ± 4 73 41
14 10 60 ± 2.3 86 29
20,000 7 4 10 54 ± 5.8 3 445 ± 3 269 113
14 10 41 ± 1.1 181 177
Data is presented as mean ± standard error of the mean. Data is representative of 3–4 passages with total spectra recordings (denoted by spectra) dependent on
spheroid size and time. Clear spectra did not require extra sampling. This is due to 2–3 spheroids on average being used for the smaller size category to obtain a clear
line width spectra, while 1–2 spheroids are required for the large size category (20,000 cells/spheroids). Seeding is representative of cells per spheroid (200 µL volume).
FIGURE 3 | Impact of varying cell seeding densities on the formation of
oxygen micro-environments. No significant differences were observed in the
formation of oxygen microenvironment (p > 0.05). As denoted by the legend,
is representative of samples collected on day 7 where cells have become
confluent in cell culture model and is representative of samples collected on
day 14.
not directly metabolize testosterone to 6β-hydroxytestosterone as
predicted in other tissue models (e.g., liver) (Nabb et al., 2006).
DISCUSSION
Propranolol metabolism is complex. In mammals we
understand there are three hepatic pathways: hydroxylation
of the naphthalene ring, and two processes focused on the
decomposition of the side chain, that are glucuronidation
and N-desisopropylation that together provide 14 potential
metabolites (see Supplementary File for details and diagrams).
In fish we understand little of which of these potential paths
and processes are active. In this study, different sized spheroids
FIGURE 4 | Substrate depletion of propranolol over time using two different
cell seeding densities. Each treatment is repeated in quadruplicate over 4
non-parallel passages (n = 4). No significant difference in terms of metabolism
was observed between the two seeding densities (p = 0.80; ns), but was
found to be different over time (p < 0.001). As previously outlined in Figure 3,
is representative of samples collected immediately following exposure with
no active metabolism of product, while is indicative of samples collected
after 24 h of metabolism by the spheroid model.
initiated through augmentation of initial cell seeding were
characterized. As previously observed using the RTG-2 cell line,
spheroid diameter appears to stabilize after 7 days in culture
over all seeding densities investigated (Langan et al., 2016). Until
recently, little attention was devoted to the impact that spheroid
size will play on active metabolism, but a recent review reiterates
the importance of spheroid size with respect of response to
treatment in multicellular tumor spheroids (Hirschhaeuser et al.,
2010). Of note is the emphasis placed on the establishment
of pathophysiological gradients or micro-environments where
proliferative cells are arranged in a concentric pattern around a
hypoxic/necrotic core, which is common in tumor formation.
Unusually, the establishment of this micro-environment was
also shown by us in another fish cell line derived spheroids,
with an increase in hypoxic zone congruent to increased size
(Langan et al., 2016), a finding also observed in the present
study with RTgutGC derived spheroids. Remarkably, although
Frontiers in Pharmacology | www.frontiersin.org 6 August 2018 | Volume 9 | Article 947
fphar-09-00947 August 22, 2018 Time: 12:33 # 7
Langan et al. Spheroid Size and Metabolism of Propranolol
similar seeding densities were used in both studies and spheroid
size was comparable (e.g., at a seeding of 100 × 104 cells/mL,
spheroids of size 445 ± 3 and 450 ± 43 µm were obtained
for the RTgutGC and RTG-2 cell lines respectively), oxygen
saturation differed markedly (∼20%) between the two models
with RTgutGC equivalent to 54% oxygen saturation and RTG-2
equivalent to 34% on day 7. In addition, spheroid size, diffusion
distance and quantification of viable rim also differed between
these two models, and among different seeding densities and
spheroid size. The difference between models highlights the
importance of characterizing each model derived from different
cell line/tissue origin, including for spheroids originating from
different tumors. Assuming broad comparability could provide
misleading biological information particularly when assessing
metabolism and biological responses of different chemicals or
drugs including for spheroids derived from different malignant
cell lines which have many clinical applications. This also appears
fundamentally important for the application of theoretical or
mathematical approaches to characterize zones in spheroid
models.
The transport of compounds through cell membranes is
a well-known feature in the determination of xenobiotic
detoxification. This feature has a key impact on absorption
potential, distribution, elimination, toxicity and especially
efficacy of compounds as noted in cancer spheroid models
(Achilli et al., 2014). Spheroids are aggregates of cells derived
from either primary or established cell lines which have been
shown to recapitulate some native architecture and capacity
for xenobiotic metabolism and elimination of compounds
(Hirschhaeuser et al., 2010; Baron et al., 2012; Mehta et al.,
2012; Uchea et al., 2015). However, they suffer from some
limitations in terms of micro-environment formation (Mehta
et al., 2012). Yet this formation of micro-environment can be
minimized following thorough characterization and optimization
of model particulars (Langan et al., 2016). Importantly, until
recently thorough characterization of fish spheroid models
in terms of micro-environment formation has been lacking.
This could potentially influence wider application of this
animal alternative system through valid concerns regarding their
capacity to replace complex in vivo animal systems. In this
study, the use of the fish derived intestinal RTgutGC cell line
cultured as a spheroid has previously demonstrated comparative
morphological developments in terms of numerous polarized
micro villi formations (with glycocalyx coatings) on the edge
of the spheroid structure indicative of goblet cells which are
comparable to expression of in vivo trout intestine. In addition,
unlike those spheroid models which increase in size over time,
the RTgutGC model appears to condense over time (across
all seeding densities) becoming a stable volume at 7 days as
previously reported by us in the RTG-2 cell line (Langan et al.,
2016). Two explanations for this phenomenon are proposed.
Compression of spheroid size over time may be directly related
to cells achieving confluence under normal growth conditions,
which has been previously reported in other spheroid models
(Alessandri et al., 2013). However, an alternative explanation
is also proposed surrounding the cellular architecture itself.
Examination of the RTgutGC cell line during monolayer growth
reveals attachment of the cells using elaborate interdigitations
(interlocking of parts by finger-like processes) to connect cells.
We postulate that the decrease in spheroid size over time is due to
connections between these interdigitations increasing the cellular
connectivity. As a consequence, spheroid compactness naturally
increases and would result in the increased expression of tight
junctional proteins such as ZO-1 and E-cadherin.
As demonstrated in the current study, the RTgutGC cell
line is capable of metabolizing propranolol (indicated through
compound depletion) with metabolic rate being linked with
spheroid size. The use of spheroids in uptake and diffusion
studies is increasingly revealing new insights pertaining to drug
metabolism and effects in the cellular environment (Achilli et al.,
2014). However, it is important to note that such studies used
smaller sized spheroids (<100 µm) which could have an impact
on the rate of metabolism. Our study demonstrates that for
the fish based intestinal RTgutGC model, spheroids below the
size of 500 µm do not demonstrate a significant impact on
xenobiotic metabolism. Yet, examination of the results suggest
a trend toward higher metabolism in the smaller spheroid size
(143 ± 4 µm; 50 × 104 cells/mL) at 25% than compared to the
larger spheroid (445 ± 2.56 µm; 100 × 104 cells/mL) at 15%.
This suggests that metabolic activity within this model may be
directly related to the viability and activity of the cells within
the spheroid, with larger spheroids having demonstratively less
oxygen diffusing into the system then their smaller counterparts.
As a consequence of this limited amount of oxygen in larger
spheroids, cellular stress is prevalent and thereby the scope for
normal cellular activity in terms of metabolism is reduced to
maintain basic functionality in the larger spheroids. Interestingly,
a strong negative relationship was found between metabolism
and the formation of zones of hypoxia and quiescence, which
would suggest that diffusion from external media to the cellular
body is significantly influenced by the formation of boundaries
in spheroid models. As would be expected, the spheroid size and
cell seeding show significantly strong positive relationships with
micro-environment formation, a finding supported by tumor
models which note that boundary formation is influenced mainly
by oxygen diffusion limits (Grimes et al., 2014).
The liver has long been considered the primary organ
responsible for drug metabolism, with several studies addressing
hepatic clearance of propranolol in both murine (Xu et al., 2003;
Okabe et al., 2004) and aquatic systems (Owen et al., 2009;
Bartram et al., 2012; Baron et al., 2017). Owen et al. (2007) has
also compared and contrasted hepatic clearance of β-blockers
between mammals and fish. However, in fish, Randall et al.
(1998) first suggested that uptake of this drug was most likely
to occur via the gills due to its low lipophilicity (log Dow = 1.2,
pH 7.2), a finding supported recently by Stott et al. (2015) who
identified rapid uptake of propranolol in the gills of rainbow
trout. Although a general consensus emerges in the literature
of hepatic first pass metabolism for propranolol, recent studies
have recognized that the liver is not singularly responsible for all
xenobiotic metabolism. Indeed, most drug metabolizing enzymes
present in the liver are also found in the intestine albeit at
much lower levels. For example, in rabbits, propranolol uptake
was observed in the intestine at 43% (liver of 96–97%) (Du
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Souich et al., 1995), while rat models have also demonstrated
active metabolism in the intestine via simple passive diffusion
(Masaki et al., 2006). Our results suggest that propranolol uptake
in the intestinal cells occurs via transcellular pathways given
that spheroids needed to be disaggregated in order to measure
propranolol in the experimental samples. While the suggestion
of transcellular uptake is supported in the murine intestinal
literature (Dixit et al., 2012), data collected during our study
of the metabolism of propranolol within this intestinal cell line
suggests that these processes are not singularly controlled by the
CYP pathways and warrant further investigations. The current
study emphasizes that a large suite of chemicals still need to
be tested with fish based spheroid systems in order to reach a
consensus on whether micro-environment formation in these
constructs will negatively impact on the xenobiotic metabolism
of compounds with diverse modes and mechanisms of action.
In this context, as mentioned earlier, it is crucial to investigate
differences between spheroids derived from different tissues (cell
lines), primary cultures or laboratory animals. This may have
significant impacts in the form of type I or type II errors in hazard
assessment if these constructs were adopted in a regulatory
context. Although recent research from our laboratory suggested
that fresh hepatocytes cultured as spheroids demonstrate some
aspects of the in vivo situation with respect to compounds such as
propranolol and diclofenac, it was suggested that further studies
are urgently needed at both in vitro and in vivo level to determine
the sensitivity of 3D models in predicting whole animal responses
with respect to biotransformation (Baron et al., 2017).
Studies evaluating and supporting the combined testing of
both intestinal and hepatic metabolism, either in vivo or in vitro
are increasing (Triebskorn et al., 2004; Martignoni et al., 2006;
Masaki et al., 2006; Kajbaf et al., 2013). Research to improve
the complexity of in vitro toxicity assessment has seen an
increase in the reporting of co-culturing of various organs/cell
types to address the biological complexity of uptake (e.g., Abu-
Absi et al., 2004; Yoshikawa et al., 2011; Le Hegarat et al.,
2012). Intrinsic to this is the inherent difference in metabolic
enzymes between organs being a significant driver of observed
metabolism difference. Previous studies have supported the use
of testosterone as a control CYP3A inducer in both intestinal
and hepatic cultures (Watanabe et al., 2007; Kamiguchi et al.,
2010), however, this induction was not repeatable using the
RTgutGC cell line which produced no discernible metabolites
when compared to standards. A suggestion for this lack of
metabolite formation is suggested in the mammalian literature
where Martignoni et al. (2006) reported higher levels of
6β-hydroxytestosterone in the liver compared to the intestine,
and the reverse of this trend for 16-β-hydroxytestosterone.
This would suggest the requirement of a different product
as a control substance to measure metabolic activity in the
intestinal cell line. In rat intestinal microsomes, Kajbaf et al.
(2013) previously reported a lack of testosterone transformation
to 6-β-hydroxytestosterone, while James et al. (2005) reported
that fish diet and intestinal region can also influence CYP3A
activity, with little activity reported in the distal region of
the intestine (mid and posterior). The current study found
no active transformation of testosterone in the RTgutGC cell
line which was originally developed from the distal intestine of
rainbow trout. However, when fish intestinal primary cultures
are contrasted, a different picture emerges which is more
comparable to the mammalian ex vivo literature whereby three
unknown peaks are suggested by the chromatogram, and no
difference observed between intestinal regions. The presence
of CYP3A and the efflux transported P-glycoprotein have
already been established in RTgutGC cell line under different
exposure conditions (Langan et al., 2017) indicating its metabolic
competence, and the lack of metabolism of testosterone does not
appear to impact the metabolism of propranolol outlined in this
study. Foreseeable reasons for this are found in murine systems
which reports that propranolol is taken up via simple diffusion
without the participation of efflux transporters at an apical pH of
7.4 (Masaki et al., 2006). However, most previous studies of fish
CYP metabolism in pollutant biotransformation have focused on
the CYP1A family, with further studies required on the induction
of CYP3A (James et al., 2005).
As previously outlined, most studies do not justify the use
of small (or large) spheroids for drug uptake to investigate
metabolism. The data indicates that spheroids with a size of
less than 200 µm would be preferable to use when extreme
micro-environments which can affect cellular metabolism
should be kept to a minimum. To the our knowledge, the
present study presents the first study addressing why the use
of different sized spheroids may negatively/adversely impact
uptake and xenobiotic metabolism through the formation of
micro-environments which could be detrimental to cellular
health and activity in a non-tumor spheroid model. In order
to utilize the spheroid model, a thorough characterization of
all spheroid models derived from different organs should be
undertaken to establish baseline data to facilitate comparison.
In this instance, we have begun this with the current study
and previous work (Langan et al., 2016). Given the minimal
information available in terms of dietary uptake of contaminants,
it is, however, vital that organs such as the liver are also
investigated to compare differences in metabolic response to
really understand the benefits and limitations of these 3D
constructs.
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